Description
| Product Name | CAT.No | Size |
| Anti-KPa | BGBKPA02 | 1 x 2ml |
| Anti-KPb | BGBKPB02 | 1 x 2ml |
Product Description
The Biorex Diagnostics Anti-KPa and Anti-KPb reagents are ready-to-use solutions for the accurate detection of the KPa and KPb antigens in the Kell (KEL) blood group system. These minor but clinically significant antigens are important in transfusion medicine, as they can cause haemolytic transfusion reactions (HTRs) and haemolytic disease of the newborn (HDN) if not properly identified. Reliable detection of these antigens is therefore essential for ensuring transfusion safety, antenatal monitoring, and extended phenotyping.
Key Features
• Accurate KPa and KPb antigen detection – identifies KPa-positive, KPa-negative, KPb-positive, and KPb-negative red cells
• Indirect antiglobulin method – highly sensitive detection of antigen expression in donor and patient samples
• Clinically significant – supports prevention of HTRs and HDN by detecting minor but relevant antigens
• Ready-to-use format – eliminates preparation steps and dilution, saving laboratory time and reducing errors
• High-quality formulation – human serum with stabilisers such as bovine albumin and macromolecular potentiators ensures consistent and reproducible results
Benefits
Use of the Anti-KPa and Anti-KPb reagents enables accurate identification of minor Kell antigens, enhancing transfusion safety and supporting safe donor–recipient matching. Their high specificity and reproducible performance minimise the risk of alloimmunisation in sensitised patients and improve the reliability of antibody investigations. The ready-to-use format and stable liquid formulation simplify laboratory workflow, reduce handling errors, and facilitate efficient blood typing, antenatal screening, and extended phenotyping panels. These reagents are suitable for routine immunohaematology testing in blood banks, hospitals, and reference laboratories, providing clinicians and laboratory professionals with dependable tools for safe transfusion practices. Routine use of Anti-KPa and Anti-KPb ensures comprehensive detection of clinically relevant antigens, supporting accurate immunohaematology diagnostics, enhancing patient care, and helping prevent complications associated with mismatched transfusions. Their combination of sensitivity, stability, and ease of use makes them indispensable for laboratories performing extended Kell system phenotyping and high-quality transfusion safety testing..
Contact Us for more information.